Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim results

30th May 2025 13:59

RNS Number : 8491K
Cel AI PLC
30 May 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Press release

30 May 2025

 

 

 

 

 Cel AI PLC

 

("Cel AI " or "the Company")

 

Interim results

 

Cel AI (LSE: CLAI), announces its unaudited half-year results to 28 February 2025.

The directors of Cel AI accept responsibility for this announcement.

 

For further information please contact:

 

Cel AI

 

Director

Olivia Edwards

 

via FSCF

First Sentinel Corporate Finance (FSCF)

 

Financial Adviser

Brian Stockbridge

 

+44 7858 888 007

 

 

 

Chairperson's Statement

I am pleased to present Cel AI's interim results for the six months ended 28 February 2025, which demonstrate significant progress in our strategic transformation and operational discipline.

Financial Performance and Cost Management

During the period, we took the strategic decision to invest a significant amount of our remaining free cash into Solana, aligning with our technology-forward approach and providing potential diversification benefits to our treasury management. We have further enhanced this strategy by staking our SOL onto a Delegator, which generates additional SOL as yield. We have the option of liquidating this yield to assist with operational expenses or to reinvest elsewhere, creating a sustainable revenue stream to support our operations.

 

As at the date of signing these financial statements, our digital asset portfolio has grown to a carrying value of approximately £462,000, comprising 3,407 SOL tokens and diversified holdings in complementary digital assets. This performance demonstrates both the substantial growth potential of our digital asset strategy and its meaningful contribution to strengthening our financial position.

Recent Corporate Developments

Post-period end, we successfully completed a £250,000 fundraise through an institutional placing. The funds were raised at 0.225p per share, with 111,111,111 new ordinary shares issued to institutional investors.

 

Importantly, we have launched our Bitcoin Treasury Reserve Strategy, joining a growing cohort of public companies integrating digital assets into corporate treasury management. This strategy follows successful examples set by companies such as MicroStrategy, Tesla, Tokyo-listed Metaplanet Inc., and more recently UK-listed Smarter Web Company plc and Coinsilium Group Limited., all of whom have demonstrated how disciplined Bitcoin treasury management can create significant shareholder value and signal technological leadership.

 

The net proceeds from our recent fundraise will be used to acquire Bitcoin and fund ongoing operations, enhancing our capital allocation flexibility and providing a potential hedge against inflation while diversifying our balance sheet.

Outlook

The transformation we have achieved in controlling our cost base, combined with our innovative approach to treasury management and the successful completion of our fundraise positions Cel AI well for the future. We are excited to execute our Bitcoin Treasury Reserve Strategy while remaining focused on maintaining the operational discipline that has characterized this period.

We continue to believe in the long-term potential of our technology platform and remain committed to creating sustainable value for our shareholders.

Olivia Edwards

Chairperson of Cel AI Plc

 

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME

 

Notes

Six months to 28 February 2025

Six months to 29 February 2024

 

Year ended 31 August 2024

 

 

£

£

£

Revenue

 

0

17,941

17,942

Cost of sales

 

(0)

(7,682)

(7,683)

Gross profit

 

0

10,259

10,259

 

 

Administrative expenses

 

(149,638)

(627,078)

(1,859,240)

 

 

Operating loss

4

(149,638)

(626,819)

(1,848,981)

 

 

Finance income

 

19,888

13,200

21,520

 

 

Loss before taxation

 

(129,750)

(603,619)

(1,827,461)

 

 

Taxation

 

-

-

-

 

 

Loss after taxation

 

(129,750)

(603,619)

(1,827,461)

 

 

Other comprehensive loss Translation of foreign operations

 

(0)

 

(580)

 

(3979)

31,784

 

 

Total comprehensive loss for the period

 

(129,750)

(604,199)

(1,799,656)

 

 

Basic and diluted loss per share - pence

5

0.00022

0.11

0.303

 

 

 

All transactions arise from continuing operations.

 

The accompanying accounting policies and notes form an integral part of these unaudited interim financial statements.

CONDENSED STATEMENT OF FINANCIAL POSITION

 

 

 

As at 28February 2025

 

As at 29 February 2024

 

As at 31

 August 2024

 

Notes

£

£

£

 

 

ASSETS

 

Current & Non-Current Assets

 

Intangible

 

434,751

0,00

431,784

Trade and other receivables

6

14,949

146,426

9,570

Cash and cash equivalents

 

19,171

1,000,992

213,627

Inventory

 

0

583,625

0,00

 

 

TOTAL ASSETS

 

468,871

1,731,043

654,981

 

 

 

EQUITY AND LIABILITIES

 

 

 

 

Current liabilities

 

 

Trade and other payables

7

(58,361)

(65,223)

(140,427)

 

 

TOTAL LIABILITIES

(58,361)

(65,223)

(140,427)

 

 

 

NET ASSETS

410,512

1,665,820

514,554

 

 

 

EQUITY ATTRIBUTABLE

TO SHAREHOLDERS

 

 

 

 

Share capital

8

602,250

602,250

602,250

Share premium

12,988,101

12,988,101

12,988,101

Accumulated losses

(14,992,876)

(13,644,230)

(14,836,288)

Share-based payment reserve

437,933

1,721,603

412,026

Other reserves

1,321,985

0

1,321,984

Revaluation Reserve

58,422

0

31,784

Foreign translation reserve

(5,303)

(1,904)

(5,303)

 

TOTAL EQUITY

410,512

1,665,820

514,554

 

 

The accompanying accounting policies and notes form an integral part of these unaudited interim financial statements.

CONDENSED STATEMENT OF CHANGES IN EQUITY

 

Ordinary share capital

 

 

Share premium

 

Foreign currency translation

Revaluation Reserve

Share-based payment reserve

 

 

Retained earnings

 

 

 

Total

 

£

£

£

 

£

£

£

Balance at 1 September 2023

602,250

12,988,101

(1,324)

1,714,392

(13,040,611)

2,262,808

Loss for the period

-

-

-

-

(603,619)

(603,619)

Other comprehensive income

-

-

(580)

 

 

-

-

(580)

Total comprehensive income for the period

-

-

(580)

-

(603,619)

 

(604,199)

Share-based payments

-

-

-

7,211

-

7,211

Total contribution by owners

-

-

-

7,211

-

7,211

Balance at 29 February 2024

602,250

12,988,101

(1,904)

1,721,603

 13,644,230

1,665,820

 

Balance at 1 March 2024

602,250

12,988,101

(1,904)

1,721,603

13,644,230

1,665,820

Loss for the period

-

-

-

-

(1,223,842)

(1,223,842)

Other comprehensive income

-

-

(3,399)

 

 

-

-

(3,399)

Fair Value Gain on Intangible Asset

 

31,784

31,784

Total comprehensive income for the period

-

-

(3,399)

 

31,784

-

(1,223,842)

(1,195,457)

Shares issued

-

-

Share-based payments

-

-

-

(44,191)

-

 

(44,191)

Lapsed Warrants & Share options

(13,53,768)

13,53,768

-

Total contributions by owners

-

-

-

(13,02,366)

-

564,550

Balance at 31 August 2024

602,250

12,988,101

(5,303)

 

31,784

412,026

(13,514,304)

514,554

 

 

Balance at 1 September 2024

602,250

12,988,101

(5.303)

 

31,784

412,026

(13,514,304)

514,554

Loss for the period

-

-

-

-

(129,750)

(129,750)

Other comprehensive income

-

-

(1)

 

26,638

-

-

26,637

Total comprehensive income for the period

-

-

(1)

 

26,638

-

(129,750)

 

(103,113)

Share-based payments

-

-

-

25,707

(26,836)-

(1,129)

Total contribution by owners

-

-

-

25,707

(26,836)-

(1,129)

Balance at 28 February 2025

602,250

12,988,101

(5,304)

 

58,422

437,733

(13,670,890)

410,512

The accompanying accounting policies and notes form an integral part of these unaudited interim financial statements.

 

CONDENSED STATEMENT OF CASH FLOWS

 

 

Six months to 28 February 2025

 

Six months to 29 February 2024

 

Year ended 31 August 2024

 

 

£

£

£

Cashflow from operating activities

Loss before income tax

(129,750)

(603,619)

(1,827,461)

 

Share-based payment charge

25,707

7,211

51,402

Fair Value Loss on Investment

78,660

Increase in inventory

(742)

588,545

(Gain)/loss on deregistration of a subsidiary

(94)

Increase in inventory

(5662)

Increase (Decrease) in trade & other receivable

(5,379)

(53,591)

82,96

Decrease in trade and other payable

(82,066)

(120,579)

(43,905)

Research and development non cash

-

-

-

Foreign exchange differences

(580)

(3,979)

Finance income

19,888

10,913

(21,426)

Net cash flows used in operating activities

(171,600)

(760,987)

(1,100,994)

 

Cash flows from investing activities

 

Increase in intangible assets

(2,967)

(400,000)

Increase in equity investment

(78,660)

Net cash outflow on deregistration of a

subsidiary

(1,037)

Finance income

(19,888)

(10,913)

21,426

Net cash flow from investing activity

(22,854)

(10,913)

(458,271)

 

Cash flows from financing activities

Proceeds from issue of shares, net of issue costs

-

-

 

-

Net cash inflow from financing activities

-

-

(458,271)

Net movement in cash and cash equivalents

(194,454)

(771,900)

 

(1,559,265)

Opening cash and cash equivalents

213,626

1,772,892

 

1,772,892

Closing cash and cash equivalents

19,172

1,000,992

 

213,627

 

The accompanying accounting policies and notes form an integral part of these unaudited interim financial statements.

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

1. Information on the Company

The Company is incorporated in England and Wales (registration number 11537452) and the Company's share are listed in the equity shares (transition) category of the Official List of the Financial Conduct Authority and traded on the main market of the London Stock Exchange with ticker symbol CLAI. Cel AI uses advanced cutting-edge artificial intelligence (AI) to deliver the future of personalised beauty, with tailored beauty advice and product recommendations in addition to its breakthrough skincare formulations powered by CBG.

2. Basis of preparation and principal accounting policies

This condensed consolidated interim financial information was approved for issue by the Board on Thursday 29th of May 2025.

 

The Company's directors are responsible for the preparation of the unaudited interim financial statements.

 

The preparation of unaudited interim financial statements in conformity with IFRSs requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited interim financial statements and the reported amounts of expenses during the period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.

 

The Directors consider that in the proper preparation of the unaudited interim financial statements there were no critical or significant areas which required the use of accounting estimates and exercise of judgement by management while applying the Company's accounting policies.

 

This condensed consolidated interim financial information has not been audited and does not include all of the information required for full annual financial statements. The financial figures included within this interim report have been computed in accordance with IFRS applicable to interim periods, and this report constitutes an interim financial report as set out in International Accounting Standard 34: Interim Financial Reporting.

 

There is no material difference between the fair value of financial assets and liabilities and their carrying amount.

 

The functional and presentational currency is UK Sterling.

 

3. Going concern

 

The Directors have assessed the current financial position of the Company, along with future cash flow requirements, to determine if the Company has the financial resources to continue as a going concern for the foreseeable future.

 

The conclusion of this assessment is that it is appropriate that the Company be considered a going concern. For this reason, the Directors continue to adopt the going concern basis in preparing the unaudited interim financial statements.

 

 

4. Operating loss

 

Total administrative expenses include share-based payments of £25,707 (28 February 2024: £7,211). The related credit to equity is taken to retained earnings.

 

5. Earnings per share

 

Basic earnings per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number of Ordinary Shares in issue during the period.

 

28 February 2025

29 February 2024

31 August 2024

 

£

£

£

Loss used to calculate basic and diluted earnings per share

(129,750)

(603,619)

(1,827,461)

 

Weighted average number of shares used in calculating

basic earnings per share

602,250,000

537,962,329

 

602,250,000

 

Weighted average number of shares used in calculating

diluted earnings per share

602,250,000

537,962,329

602,250,000

Basic loss per share (pence)

(0.00022)

(0.11)

(0.303)

Diluted loss per share (pence)

(0.00022)

(0.11)

(0.303)

 

6. Trade and other receivables

28 February 2025

29 February 2024

31 August 2024

£

£

£

Trade receivables

790

790

790

VAT debtor

14,159

16,115

7,627

Prepayments

 

28,437

1,153

Other debtors

 

101,084

14,949

146,426

9,570

 

There were no receivables that were past due or considered to be impaired. There is no significant difference between the fair value of the other receivables and the values stated above.

 

7. Trade and other payables

28 February 2025

29 February 2024

31 August 2024

£

£

£

Trade creditors

55,361

37,107

110,453

Accruals

3,000

23,491

29,974

Other creditors

0

4,625

-

58,361

65,223

140,427

 

All liabilities are payable on demand or have payment terms of less than 90 days.

 

 

 

 

8. Share capital

 

 

28 February

 2025

29 February

 2024

31 August

2024

 

 

£

£

£

 

602,250,000 Ordinary shares of £0.001 each

602,250

602,250

 

602,250

 

The Ordinary Shares have been classified as Equity. The Ordinary Shares have attached to them full voting and capital distribution rights.

 

9. Capital and reserves

 

Share capital represents issued Ordinary shares of £0.001 each, all of which are fully paid.

 

Share premium is the amount subscribed for share capital in excess of nominal value less attributable share issue expenses.

 

Retained earnings is the cumulative loss of the Company attributable to equity shareholders.

 

10. Share-based payments

 

The Company has a total of 59,581,594 warrants and options to subscribe for additional share capital of the Company. Each warrant entitles the holder to subscribe for one Ordinary Share in the Company. The right to convert each warrant is unconditional.

 

The right to subscribe for Ordinary Shares in the Company is subject to minimum vesting periods of up to three years.

 

 

 

 

 

 

 

Warrants issued

Weighted average exercise price (pence)

28February 2025

29 February 2024

31 August

2024

 

 

Number

Number

Number

 

 

 

 

At the beginning of the period

3.62

12,250,000

41,460,000

50,460,000

Issued in the period

0.25

23,000,000

-

14,000,000

Exercised in the period

-

-

-

(21,000,000)

Lapsed in the period

-

-

(29,210,000)

At the end of the period

1.61

35,250,000

12,250,000

12,250,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In the period, the Company issued share options to employees as follows:

 

 

Share options issued

Weighted average exercise price (pence)

28 February 2025

29 February 2024

31 August

2023

 

 

Number

Number

Number

 

 

 

 

 

At the beginning of the period

5.74p

24,331,594

24,331,594

24,331,594

Issued in period

-

-

-

-

Lapsed in the period

-

-

-

(200,000)

At the end of period

5.74p

24,331,594

24,331,594

24,131,594

 

Equity-settled share-based payments are measured at fair-value (excluding the effect of non-market-based vesting conditions) as determined through use of the Black-Scholes technique, at the date of issue.

 

Volatility for the calculation of the share-based payment charge in respect of the options issued was determined by reference to movements in the relative share prices of a selected peer-group of companies listed on the London Stock Exchange up to the date of admission and also proportionately on post admission share-price movements of the Company where relevant.

 

The total share-based payment charge in the period was £25,707, which has been charged to administrative expenses (six months to 28 February 2024: £7,211, year to 31 August 2024: £150,322) all of which was charged to administrative expenses). The share-based payment charge was calculated using the Black-Scholes model. All warrants and options have an exercise period between one and three years from the date of issue.

 

The total of the share-based payment charge has been simultaneously credited to retained earnings.

 

The total number of warrants issued to directors (including former directors) is 25,000,000 and the total number of share options issued to directors (including former directors is Nil.

 

 

Share-based payment charge for the period

28 February 2025

29 February 2024

31 August

2024

 

£

£

£

 

 

 

 

Administrative expenses

25,707

7,211

51,402

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR LBLFXEELEBBE

Related Shares:

Cel Ai
FTSE 100 Latest
Value8,772.38
Change55.93